Drugs / cyclopentolate
cyclopentolate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CYCLOGYL | — | 1974-07-31 | fda.gov ↗ |
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT03638726 | Sep 2018 → Mar 2019 | cataract | Dar El Oyoun Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02177539 | May → Aug 2014 | refractive error | Pontificia Universidad Catolica de Chile | Unknown | No outcome recorded |
| Phase 4 | NCT04838665 | Sep 2011 | retinopathy of prematurity | University of the Philippines | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT06914063 | Mar → Jun 2025 overdue | cycloplegia | Superior University | Active not recruiting | No outcome recorded |
| — | NCT05614622 | Nov 2020 → Jan 2022 | — | Rabin Medical Center | Completed | No outcome recorded |
| — | NCT02909140 | Sep 2016 → Aug 2018 | cataract | Johns Hopkins University | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT01054027 | Mar → Nov 2007 | retinopathy of prematurity | Georgetown University | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1 | NCT00348166 Background | Dec 2005 → Jun 2008 | myopia | KK Women's and Children's Hospital | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03851172 Background | Mar → Dec 2019 | cataract | Assiut University | Unknown | No outcome recorded |
| Phase 3 | NCT02717871 Comparator | Mar 2016 → Oct 2020 | keratitis | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 4 | NCT06077682 Comparator | Sep 2023 → Sep 2024 | cycloplegia, esotropia, refractive error, vision disorder | Islamic Hospital, Jordan | Unknown | No outcome recorded |
| Phase 4 | NCT05442801 Comparator | Mar → Jun 2022 | cycloplegia | Islamic Hospital, Jordan | Completed | No outcome recorded |
| — | NCT05204069 Background | Jan → Sep 2021 | amblyopia, anisometropia, strabismus | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cyclopentolate | “Conventional Cycloplegic Drops (e.g., cyclopentolate) to provide a baseline for comparison with the rapid-onset treatment.” NCT06914063 ↗ |
| Known as | Cyclopentolate Hydrochloride | “Multiple Alternate Instillation of Cyclopentolate Hydrochloride Dilate® Micro Labs Limited Bangalore and Phenylephrine Hydrochloride Mydfrin™ 25mg/mL (2.5%) Alcon Fort Worth Texas” NCT04838665 ↗1“Cyclopentolate Hydrochloride 1.0% eye drops” NCT05614622 ↗ |
| Known as | Dilate | “Multiple Alternate Instillation of Cyclopentolate Hydrochloride Dilate® Micro Labs Limited Bangalore and Phenylephrine Hydrochloride Mydfrin™ 25mg/mL (2.5%) Alcon Fort Worth Texas” NCT04838665 ↗ |
| Route | Topical | “given as drops, prior to eye exam” NCT01054027 ↗ |